Legislative Research: US HB7032 | 2021-2022 | 117th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 118th Congress (Passed) | To amend the Congressional Budget and Impoundment Control Act of 1974 to provide the Congressional Budget Office with necessary authorities to expedite the sharing of data from executive branch agencies, and for other purposes. [HB7032 2023 Detail][HB7032 2023 Text][HB7032 2023 Comments] | 2024-09-30 Became Public Law No: 118-89. |
| 2021-2022 117th Congress (Introduced - Dead) | To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)) with respect to a process to inform persons submitting an abbreviated application for a new drug whether the new drug is qualitatively or quantitatively the same a... [HB7032 2021 Detail][HB7032 2021 Text][HB7032 2021 Comments] | 2022-03-10 Referred to the Subcommittee on Health. |
| 2019-2020 116th Congress (Introduced - Dead) | Allows eligible individuals a refundable tax credit, up to $4,000 in a taxable year, for expenses paid for qualified training services. The bill defines qualified training service as a course or program of study that is listed in provisions of the Wo... [HB7032 2019 Detail][HB7032 2019 Text][HB7032 2019 Comments] | 2020-05-27 Referred to the House Committee on Ways and Means. |
| 2017-2018 115th Congress (Introduced - Dead) | Adam S. Lovinger Whistleblower Reprisal Act of 2018 [HB7032 2017 Detail][HB7032 2017 Text][HB7032 2017 Comments] | 2018-10-05 Referred to the House Committee on Oversight and Government Reform. |
References Online
| Search Phrase | Web | News | Financial | Financial | Encylopedia | Biography | BioGuide |
|---|---|---|---|---|---|---|---|
| [US Congress HB7032] | Google Web | Google News | |||||
| [US Congress House Subcommittee on Health Committee] | Google Web | Google News | N/A | ||||
| [Representative Ann Kuster US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Representative Kim Schrier US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
Legislative Citation
APA
US HB7032 | 2021-2022 | 117th Congress. (2022, March 10). LegiScan. Retrieved December 23, 2024, from https://legiscan.com/US/bill/HB7032/2021
MLA
"US HB7032 | 2021-2022 | 117th Congress." LegiScan. LegiScan LLC, 10 Mar. 2022. Web. 23 Dec. 2024. <https://legiscan.com/US/bill/HB7032/2021>.
Chicago
"US HB7032 | 2021-2022 | 117th Congress." March 10, 2022 LegiScan. Accessed December 23, 2024. https://legiscan.com/US/bill/HB7032/2021.
Turabian
LegiScan. US HB7032 | 2021-2022 | 117th Congress. 10 March 2022. https://legiscan.com/US/bill/HB7032/2021 (accessed December 23, 2024).
Subjects
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| HB7667 | Related | 2022-06-09 | Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 | Received in the Senate. |
| SB4338 | Related | 2022-05-26 | Increasing Transparency in Generic Drug Applications Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7032/all-info |
| Text | https://www.congress.gov/117/bills/hr7032/BILLS-117hr7032ih.pdf |
